Jasmine H Francis1, Tatyana Milman2, Hans Grossniklaus3, Daniel Albert4, Robert Folberg5, Gregory Levitin6, Sarah Coupland7, Federica Catalanotti8, David Rabady9, Cyriac Kandoth8, Klaus Busam10, David Abramson10. 1. Memorial Sloan-Kettering Cancer Center, New York, New York; Weill Cornell Medical Center, New York, New York. Electronic address: francij1@mskcc.org. 2. Departments of Ophthalmology and Pathology, Wills Eye Hospital and Thomas Jefferson University Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania. 3. Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia. 4. McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, Wisconsin. 5. Oakland University William Beaumont School of Medicine, Rochester, Michigan. 6. New York Eye and Ear Infirmary of Mount Sinai, New York, New York. 7. Department of Cellular and Molecular Medicine, University of Liverpool, Liverpool, United Kingdom. 8. Memorial Sloan-Kettering Cancer Center, New York, New York. 9. Ophthalmic Consultants of the Capital Region, Albany, New York. 10. Memorial Sloan-Kettering Cancer Center, New York, New York; Weill Cornell Medical Center, New York, New York.
Abstract
PURPOSE: GNAQ mutations have been identified in port wine stains (both syndromic and nonsyndromic) and melanocytic ocular neoplasms. This study investigates the presence of GNAQ mutations in diffuse (those associated with Sturge-Weber syndrome [SWS]) and solitary choroidal hemangiomas. PARTICIPANTS: Tissue from 11 patients with the following diagnoses: port wine stain (n = 3), diffuse choroidal hemangioma (n = 1), solitary choroidal hemangioma (n = 6), and choroidal nevus (n = 1). METHODS: Ten specimens were interrogated with Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets, a hybridization capture-based next-generation sequencing assay for targeted deep sequencing of all exons and selected introns of 468 key cancer genes in formalin-fixed, paraffin-embedded tumors. Digital polymerase chain reaction was used to detect GNAQ Q209 mutation in 1 specimen. MAIN OUTCOME MEASURES: Detection of GNAQ codon-specific mutation. RESULTS: Activating somatic GNAQ mutations (c.547C > T; p.Arg183Cys) were found in 100% (3 of 3) of the port wine stain and in the diffuse choroidal hemangioma. Somatic GNAQ mutations (c.626A > T; p.Gln209Leu) were found in 100% (6 of 6) of the solitary choroidal hemangiomas and (c.626A > C; p.Gln209Pro) in the choroidal nevus. CONCLUSIONS: GNAQ mutations occur in both diffuse and solitary hemangiomas, although at distinct codons. An R183 codon is mutant in diffuse choroidal hemangiomas, consistent with other Sturge-Weber vascular malformations. By contrast, solitary choroidal hemangiomas have mutations in the Q209 codon, similar to other intraocular melanocytic neoplasms.
PURPOSE:GNAQ mutations have been identified in port wine stains (both syndromic and nonsyndromic) and melanocytic ocular neoplasms. This study investigates the presence of GNAQ mutations in diffuse (those associated with Sturge-Weber syndrome [SWS]) and solitary choroidal hemangiomas. PARTICIPANTS: Tissue from 11 patients with the following diagnoses: port wine stain (n = 3), diffuse choroidal hemangioma (n = 1), solitary choroidal hemangioma (n = 6), and choroidal nevus (n = 1). METHODS: Ten specimens were interrogated with Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets, a hybridization capture-based next-generation sequencing assay for targeted deep sequencing of all exons and selected introns of 468 key cancer genes in formalin-fixed, paraffin-embedded tumors. Digital polymerase chain reaction was used to detect GNAQ Q209 mutation in 1 specimen. MAIN OUTCOME MEASURES: Detection of GNAQ codon-specific mutation. RESULTS: Activating somatic GNAQ mutations (c.547C > T; p.Arg183Cys) were found in 100% (3 of 3) of the port wine stain and in the diffuse choroidal hemangioma. Somatic GNAQ mutations (c.626A > T; p.Gln209Leu) were found in 100% (6 of 6) of the solitary choroidal hemangiomas and (c.626A > C; p.Gln209Pro) in the choroidal nevus. CONCLUSIONS:GNAQ mutations occur in both diffuse and solitary hemangiomas, although at distinct codons. An R183 codon is mutant in diffuse choroidal hemangiomas, consistent with other Sturge-Weber vascular malformations. By contrast, solitary choroidal hemangiomas have mutations in the Q209 codon, similar to other intraocular melanocytic neoplasms.
Authors: Reid Wilkins; Elcin Zan; Olga Leonardi; Kepal N Patel; Adam S Jacobson; George Jour; Cheng Z Liu; Fang Zhou Journal: Head Neck Pathol Date: 2022-10-18
Authors: Ana Boned-Murillo; Maria Dolores Diaz-Barreda; Ana Honrubia-Grijalbo; Olivia Esteban-Floria; Francisco Javier Ascaso Puyuelo Journal: Case Rep Ophthalmol Date: 2021-05-11
Authors: Claudia H D Le Guin; Norbert Bornfeld; Nikolaos E Bechrakis; Leyla Jabbarli; Heike Richly; Dietmar R Lohmann; Michael Zeschnigk Journal: Cancer Med Date: 2021-07-21 Impact factor: 4.452